Bristol-Myers Squibb Co (NYSE: BMY) kicked off on Monday, down -2.19% from the previous trading day, before settling in for the closing price of $49.75. Over the past 52 weeks, BMY has traded in a range of $39.35-$63.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 13.06% over the last five years. While this was happening, its average annual earnings per share was recorded 490.07%. With a float of $2.03 billion, this company’s outstanding shares have now reached $2.04 billion.
The firm has a total of 34100 workers. Let’s measure their productivity. In terms of profitability, gross margin is 65.99%, operating margin of 18.45%, and the pretax margin is 12.82%.
Bristol-Myers Squibb Co (BMY) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Bristol-Myers Squibb Co is 0.10%, while institutional ownership is 81.61%. The most recent insider transaction that took place on May 09 ’25, was worth 3,702. In this transaction President, RayzeBio Org. of this company sold 97 shares at a rate of $38.01, taking the stock ownership to the 0 shares. Before that another transaction happened on Apr 25 ’25, when Company’s EVP,Chief Med.Offr.,Drug Dev. bought 4,250 for $47.58, making the entire transaction worth $202,215. This insider now owns 83,513 shares in total.
Bristol-Myers Squibb Co (BMY) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 490.07% per share during the next fiscal year.
Bristol-Myers Squibb Co (NYSE: BMY) Trading Performance Indicators
Take a look at Bristol-Myers Squibb Co’s (BMY) current performance indicators. Last quarter, stock had a quick ratio of 1.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.08. Likewise, its price to free cash flow for the trailing twelve months is 7.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.66, a number that is poised to hit 1.61 in the next quarter and is forecasted to reach 6.05 in one year’s time.
Technical Analysis of Bristol-Myers Squibb Co (BMY)
Analysing the last 5-days average volume posted by the [Bristol-Myers Squibb Co, BMY], we can find that recorded value of 11.3 million was lower than the volume posted last year of 13.25 million. As of the previous 9 days, the stock’s Stochastic %D was 65.32%. Additionally, its Average True Range was 1.19.
During the past 100 days, Bristol-Myers Squibb Co’s (BMY) raw stochastic average was set at 24.11%, which indicates a significant decrease from 54.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.28% in the past 14 days, which was lower than the 32.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.91, while its 200-day Moving Average is $54.19. Now, the first resistance to watch is $49.32. This is followed by the second major resistance level at $49.97. The third major resistance level sits at $50.51. If the price goes on to break the first support level at $48.13, it is likely to go to the next support level at $47.59. Should the price break the second support level, the third support level stands at $46.94.
Bristol-Myers Squibb Co (NYSE: BMY) Key Stats
The company with the Market Capitalisation of 99.03 billion has total of 2,035,081K Shares Outstanding. Its annual sales at the moment are 48,300 M in contrast with the sum of -8,948 M annual income. Company’s last quarter sales were recorded 11,201 M and last quarter income was 2,456 M.
